플라즈맵

405000· KOSDAQ· Health Care· Health Care Equipment & Services

₩4,650+9.15%

2026-08-04

Financials

Valuation Metrics

플라즈맵's Market Cap is ₩178B. At end of 2025 it was ₩223B. Ranked #2354 of 2,436 in KR market (top 97%), #1575 of 1,649 on KOSDAQ (top 96%), #95 of 96 in Health Care Equipment & Services (top 99%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	17.85B KRW	KR#2,354/2,436 Sec#95/96
Revenue	10.26B KRW	KR#2,285/2,436 Sec#81/96
Net Income	-6.24B KRW	KR—/2,436 Sec—/96
Total Assets	18.70B KRW	KR#2,371/2,436 Sec#94/96
Net Assets	3.48B KRW	KR#2,390/2,436 Sec#95/96
Employees	91	KR#1,698/2,436 Sec#64/96
Value
P/B	5.13x	KR#2,242/2,436 Sec#84/96
P/S	1.74x	KR#1,749/2,436 Sec#45/96
FCF Yield	-26.90%	KR—/2,436 Sec—/96
Profitability
ROE	-179.38%	KR#2,371/2,436 Sec#94/96
ROA	-33.38%	KR#2,319/2,436 Sec#89/96
Op. Margin	-73.85%	KR#2,280/2,436 Sec#80/96
Revenue Growth	170.81%	KR#75/2,436 Sec#5/96
Financial Health
Debt Ratio	537.43%	KR#2,315/2,436 Sec#95/96
Total Debt	10.95B KRW	KR#1,594/2,436 Sec#50/96
FCF	-4.80B KRW	KR#1,492/2,436 Sec#50/96
Cash	2.18B KRW	KR#2,227/2,436 Sec#91/96
Current Ratio	0.96x	KR#1,865/2,436 Sec#82/96
Performance
1Y Return	-41.51%	KR#1,876/2,436 Sec#67/96
1M Return	30.80%	KR#62/2,436 Sec#3/96
From 52W High	-50.53%	KR#1,219/2,436 Sec#46/96
1Y MDD	-63.79%	KR#1,629/2,436 Sec#54/96
Trading
Volume	15,353 shares	KR#1,975/2,436 Sec#83/96
Foreign Own.	16.16%	KR—/2,436 Sec—/96
Per Share
EPS	-1,666 KRW	KR—/2,436 Sec—/96
BPS	907 KRW	KR#2,303/2,436 Sec#87/96

Company Info

CEO 이윤철(단독 대표이사)

Employees 91

Founded 2015

HQ 대전광역시 유성구, KR

Website plasmapp.com/

동사는 2015년 KAIST 물리학과 실험실 창업으로 설립된 바이오 플라즈마 딥테크 기업이며, 2022년 코스닥시장에 상장했음. 플라즈마 원천기술 기반 저온멸균 솔루션, 임플란트 재생활성 솔루션, 치주·근관치료기 등 3대 제품군을 보유하고 있음. 2021년 비미국 회사 최초 FDA 인증으로 미국 진출 기반을 확보하였고, 2025년 ACTILINK가 세계 최초 인증을 받아 관련 시장 선도를 추진하고 있음. 플라즈맵는 2015년에 설립되었으며 대전광역시 유성구에 본사를 두고 있습니다.